Wajeeha Rizvi, M.D.
Hematology & Oncology Physician · Cypress, TX
Wajeeha Rizvi, M.D. is a hematology & oncology physician with a practice address in Cypress, Texas, and NPI 1154773661, issued on Jul 8, 2016. Check the license (Texas W4942, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Wajeeha Rizvi
- Credential
- M.D.
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License numbers
- W4942 TX
036158423 IL
94-08978 KS
Self-reported in NPPES; status is on the state search - Practice location
- 24510 Northwest Fwy Ste 120, Cypress, TX 77429
- Phone
- (346) 618-3460
- Enumerated
- Jul 8, 2016
- Record last updated
- Jun 15, 2026
- Fax
- (346) 618-3403
- Medicare enrollment
- Enrolled (PECOS I20220726003734); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 922 in Texas → Look up another NPI →
Also registered at 24510 Northwest Fwy Ste 120
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Peter Morgan, M.D.Radiation Oncology Physician1083853568
- Amanda Stewart, PAMedical Physician Assistant1700205291
Verify Wajeeha Rizvi in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license W4942Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
67% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
293 Medicare Part D claims for 78 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 22% of claims. 20 claims were for opioids.
Most prescribed
- Anastrozole26 claims
- Eliquis21 claims
- Hydroxyurea20 claims
- Letrozole17 claims
- Allopurinol14 claims
- Ibrance14 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $847.23
40 payments; by number, the most common kind was food and beverage; the largest payer was Incyte Corporation. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through 2 group practices
- Quincy Physicians And Surgeons Clinic, PLLCQuincy, IL
- Schuyler County Hospital DistrictRushville, IL
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Wajeeha Rizvi among 922 hematology & oncology physician records in Texas
Wajeeha Rizvi, M.D. is one of 922 hematology & oncology physician records with a practice address in Texas. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2016, is newer than 84% of them.
- NPI issued2016 · 84% of these records are older, 12% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileYes · 75% of these records are
- Graduated2011 · median 2004 among the 691 with a school on file
- Record last updated2026 · 51% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Texas
There are 922 hematology & oncology physician records in Texas.
All 922 in Texas → Every provider in Cypress → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- David Hodges, M.D.Cypress, TX 774291619101896
- Owen Ellington, M.D, J.D.Humble, TX 773961396703310
- Thomas Guerrero-Garcia, M.D.The Woodlands, TX 773851689939993
- Mohammad Khalil, M.D.Shenandoah, TX 773851669662136
- Elim KuoThe Woodlands, TX 773851780189043
- Selvi Lingam, M.DThe Woodlands, TX 773851740296466
- Dongxin Liu, MDShenandoah, TX 773851114152220
- Priya Ramshesh, MDShenandoah, TX 773851962484907
Common questions
What is Wajeeha Rizvi, M.D.'s NPI number?
Wajeeha Rizvi, M.D.'s National Provider Identifier (NPI) is 1154773661, issued on Jul 8, 2016. An NPI identifies a provider in billing; it is not a license.
Where is Wajeeha Rizvi, M.D. located?
The NPPES record lists a practice address at 24510 Northwest Fwy Ste 120, Cypress, TX, 77429. Phone: (346) 618-3460. Providers update this record themselves, so call before visiting.
How can I verify Wajeeha Rizvi, M.D.'s license?
NPPES lists Texas license number W4942, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Wajeeha Rizvi, M.D. prescribe under Medicare Part D?
In 2024, Wajeeha Rizvi, M.D. had 293 Medicare Part D claims for 78 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.